| 0 |
IMPETIGO |
1 |
0.0007 |
| 1 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 2 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 3 |
THERAPY CESSATION |
15 |
0.0003 |
| 4 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 5 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 6 |
INTENTIONAL DOSE OMISSION |
6 |
0.0002 |
| 7 |
PRODUCT USE ISSUE |
39 |
0.0002 |
| 8 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 9 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 10 |
METABOLIC DISORDER |
1 |
0.0002 |
| 11 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 12 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 13 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 14 |
ARTHROPOD BITE |
1 |
0.0001 |
| 15 |
ACNE |
10 |
0.0001 |
| 16 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 17 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 18 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 19 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 20 |
MADAROSIS |
1 |
0.0001 |
| 21 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 22 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 23 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 24 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 25 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 26 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 27 |
SINUS CONGESTION |
1 |
0.0001 |
| 28 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 29 |
PRODUCT DOSE OMISSION ISSUE |
20 |
0.0001 |
| 30 |
INSURANCE ISSUE |
1 |
0.0001 |
| 31 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 32 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 33 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 34 |
NEURALGIA |
1 |
0.0000 |
| 35 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 36 |
EAR INFECTION |
1 |
0.0000 |
| 37 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 38 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 39 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 40 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 41 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 42 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 43 |
INFLUENZA |
3 |
0.0000 |
| 44 |
WEIGHT INCREASED |
6 |
0.0000 |
| 45 |
COLITIS |
1 |
0.0000 |
| 46 |
LIVER DISORDER |
1 |
0.0000 |
| 47 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 48 |
TINNITUS |
1 |
0.0000 |
| 49 |
DRUG INEFFECTIVE |
28 |
0.0000 |
| 50 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 51 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 52 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 53 |
HERPES ZOSTER |
1 |
0.0000 |
| 54 |
NASAL CONGESTION |
1 |
0.0000 |
| 55 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 56 |
DEHYDRATION |
2 |
0.0000 |
| 57 |
FATIGUE |
11 |
0.0000 |
| 58 |
HYPOAESTHESIA |
2 |
0.0000 |
| 59 |
HOT FLUSH |
1 |
0.0000 |
| 60 |
PARAESTHESIA |
2 |
0.0000 |
| 61 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 62 |
DRY MOUTH |
1 |
0.0000 |
| 63 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 64 |
HEADACHE |
7 |
0.0000 |
| 65 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 66 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 67 |
COUGH |
3 |
0.0000 |
| 68 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 69 |
MIGRAINE |
1 |
0.0000 |
| 70 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 71 |
ALOPECIA |
2 |
0.0000 |
| 72 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 73 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 74 |
CHILLS |
1 |
0.0000 |
| 75 |
JOINT SWELLING |
1 |
0.0000 |
| 76 |
PRURITUS |
3 |
0.0000 |
| 77 |
MALAISE |
3 |
0.0000 |
| 78 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 79 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 80 |
MYALGIA |
1 |
0.0000 |
| 81 |
COVID-19 |
1 |
0.0000 |
| 82 |
ANAEMIA |
1 |
0.0000 |
| 83 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 84 |
HYPOTENSION |
1 |
0.0000 |
| 85 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 86 |
ARTHRALGIA |
2 |
0.0000 |
| 87 |
HYPERTENSION |
1 |
0.0000 |
| 88 |
DEPRESSION |
1 |
0.0000 |
| 89 |
DECREASED APPETITE |
1 |
0.0000 |
| 90 |
FEELING ABNORMAL |
1 |
0.0000 |
| 91 |
INSOMNIA |
1 |
0.0000 |
| 92 |
OFF LABEL USE |
3 |
0.0000 |
| 93 |
DIARRHOEA |
1 |
0.0000 |
| 94 |
NAUSEA |
1 |
0.0000 |
| 95 |
DEATH |
1 |
0.0000 |